FDA Approved: ABIRATERONE ACETATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Mylan's original application for Abiraterone acetate, enabling a generic version of the cancer drug used for metastatic castration-resistant pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

ORIG AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)